Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
By sourcing from a supplier that independently verifies every batch, researchers can have confidence that their experimental outcomes reflect GHK-Cu activity not assay artifacts from impurities or degradation products
10.7150/thno.19988 Theranostics 67 KibriaG.RamosE
doi: 10.1126/sciadv.abq5925 12 BestSAGubserPMSethumadhavanSKersbergenANegron AbrilYLGoldfordJet al
For researchers interested in complementary approaches to skin health, peptide serum research provides additional context on topically applied peptide formulations and their mechanisms of penetration